At Umoja, our diverse team of scientists, researchers, and drug development experts share a common mission to transform the treatment of cancer and enhance patient’s lives. Our strategy combines world-class science with meticulous attention to detail, deliberate planning, and a bold vision to dramatically impact the lives of cancer patients everywhere.
We are led by a world class team that operates on a foundation of respect for the contributions of everyone on the Umoja team.
We strive to foster and develop a unique culture centered around the idea that a great founding team plays an integral role in shaping a successful organization. Umoja respects and values the contributions of each and every team member.
Andy Scharenberg, M.D.
Co-founder and CEO
Ryan Crisman, Ph.D.
Co-founder and CTO
Tim Gardner, MBA
EVP, Strategy and Business Development
Byoung Ryu, Ph.D
SVP, Head of Vector Biology and Discovery Research
Rich Getto, MBA
SVP, Portfolio Strategy and Program Development
Nushmia Khokhar, M.D.
Chief Medical Officer
Senior Research Associate
Scientist – In Vitro Modeling Group
Sr. Dir., MSAT
Sr. Research Associate – Tissue Culture
Sr. Dir., CMC and Allogeneic Program Lead
Associate Director Facilities and Lab Ops
Director, Corporate Operations
VP, Regulatory Affairs
VP Clinical Development and Operations
Associate Dir., Medical Writing
Assistant Lab Manager
Sr. Dir., Program Mgmt
Program Lead & Clinical Operations
Principal Scientist Discovery Lead
Scientist, Vector Production
Senior Project Manager
Head of Quality
Senior Scientist, Analytical Dev (MSAT)
Associate Dir., MSAT
Sr. Scientist, Vector Process
Sr. Dir., Translational R&D (In-Vivo)
Phil S. Low, Ph.D.
Purdue University, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Michael Jensen, M.D.
Seattle Children's Hospital, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Hans-Peter Kiem, M.D., Ph.D.
Fred Hutch Endowed Chair for Cell and Gene Therapy
Rimas Orentas, Ph.D.
Ben Towne Center for Childhood Cancer
Franklin M. Berger, CFA
Co-founder and Managing Director, FMB Research